HIND earnings date and last-quarter result: next report 2026-08-13, last quarter in line, P/E -0.05. Updated 2026-07-23.
Vyome Holdings (HIND) Research Hub
Vyome Holdings (HIND) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 1.71 USD (-4.47%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.05, market cap 0.01B. This hub links to the full technical, earnings and options research available for HIND.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.71 USD (-4.47%) |
| 52-week range | 1.701 USD – 2.36 USD |
| Trend regime | Range |
| 14-day RSI | 12.8 (Oversold) |
| Trailing P/E | -0.05 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for HIND
Covered Call on HIND: how it works, illustrative setup around the real 1.71 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on HIND: how it works, illustrative setup around the real 1.71 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on HIND: how it works, illustrative setup around the real 1.71 USD price, max profit/loss, breakeven and when to use it. Educational.
HIND technical analysis: range, last 1.71 USD, RSI 12.8, 52w range 1.701 USD–2.36 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is HIND in?
Vyome Holdings (HIND) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is HIND in an uptrend or downtrend?
As of 2026-10-26, HIND is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is HIND's trailing P/E ratio?
HIND's trailing P/E is -0.05, with a market cap of 0.01B. See the earnings research page for full valuation detail.
When does HIND next report earnings?
HIND is next scheduled to report earnings on 2026-08-13.